|
|
Article: Yale Researchers Find Phenoxodiol Overwhelmingly Effective for Treating Chemo-Resistant Ovarian Cancer Cells; Data Published in Nature Publishing's Journal 'Oncogene'.
- Article from:
- PR Newswire
- Article date:
- May 1, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Phenoxodiol, a synthetic anti- cancer drug manufactured by Novogen, has been found in laboratory studies to induce cell death in 100 percent of ovarian cancer cells, including those cells resistant to conventional agents such as paclitaxel and carboplatin. The tests were conducted on human cell lines at Yale University School of Medicine.
The drug works by altering a signal pathway in cancerous cells that otherwise does not allow unhealthy cells to die. These findings indicate that the drug could be successful at treating other cancer types as well. The study is published in the May 1 issue (Volume 22:17) of "Oncogene," published by The Nature Publishing Group, ...